These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29271560)

  • 21. Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in Brazil.
    Mendes AB; Fittipaldi JA; Neves RC; Chacra AR; Moreira ED
    Acta Diabetol; 2010 Jun; 47(2):137-45. PubMed ID: 19655083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.
    Tuttle KR; Lakshmanan MC; Rayner B; Busch RS; Zimmermann AG; Woodward DB; Botros FT
    Lancet Diabetes Endocrinol; 2018 Aug; 6(8):605-617. PubMed ID: 29910024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Efficacy and Safety of Insulin Detemir Administered Once Daily According to Two Titration Algorithms (3-0-3 and 2-4-6-8) in Patients with Type 2 Diabetes Mellitus.
    Yu HM; Park KS; Hong JH; Park KY; Lee JM; Ku BJ; Kim YJ; Oh TK
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):142-148. PubMed ID: 32207274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex differences and correlates of poor glycaemic control in type 2 diabetes: a cross-sectional study in Brazil and Venezuela.
    G Duarte F; da Silva Moreira S; Almeida MDCC; de Souza Teles CA; Andrade CS; Reingold AL; Moreira ED
    BMJ Open; 2019 Mar; 9(3):e023401. PubMed ID: 30842107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct trajectories of HbA
    Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
    Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes.
    Yamada E; Okada S; Nakajima Y; Bastie C; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Ozawa A; Yamada M
    J Diabetes; 2018 Feb; 10(2):140-147. PubMed ID: 28544548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocol.
    Boucher SE; Gray AR; de Bock M; Wiltshire EJ; Galland BC; Tomlinson PA; Rayns J; MacKenzie KE; Wheeler BJ
    BMC Endocr Disord; 2019 May; 19(1):50. PubMed ID: 31109342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change.
    Hirst JA; Stevens RJ; Farmer AJ
    PLoS One; 2014; 9(3):e92458. PubMed ID: 24667212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study.
    de Sonnaville JJ; Bouma M; Colly LP; Devillé W; Wijkel D; Heine RJ
    Diabetologia; 1997 Nov; 40(11):1334-40. PubMed ID: 9389427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes.
    Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C
    J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ojo O; Ojo OO; Adebowale F; Wang XH
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
    Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of sub-optimal glycemic control among patients enrolled in a medicine dispensing programme in KwaZulu-Natal: A cohort study, 2018-2021.
    Johnston LC; Ngassa Piotie P; Maposa I; Singh S; Kuonza L; De Voux A
    Afr J Prim Health Care Fam Med; 2024 May; 16(1):e1-e12. PubMed ID: 38832377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real-world study of more than 30 000 patients in a US electronic health record database.
    Pettus JH; Zhou FL; Shepherd L; Mercaldi K; Preblick R; Hunt PR; Paranjape S; Miller KM; Edelman SV
    Diabetes Obes Metab; 2020 Apr; 22(4):622-630. PubMed ID: 31789439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme.
    Khunti K; Chen H; Cid-Ruzafa J; Fenici P; Gomes MB; Hammar N; Ji L; Kosiborod M; Pocock S; Shestakova MV; Shimomura I; Tang F; Watada H; Nicolucci A;
    Diabetes Obes Metab; 2020 Jan; 22(1):66-78. PubMed ID: 31468637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different clinical prognostic factors are associated with improved glycaemic control: findings from MARCH randomized trial.
    Han J; Yu H; Tu Y; Pang J; Liu F; Bao Y; Yang W; Jia W
    Diabet Med; 2017 Apr; 34(4):490-499. PubMed ID: 27151271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
    Whyte MB; Hinton W; McGovern A; van Vlymen J; Ferreira F; Calderara S; Mount J; Munro N; de Lusignan S
    PLoS Med; 2019 Oct; 16(10):e1002942. PubMed ID: 31589609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets.
    Migdal A; Abrahamson M; Peters A; Vint N
    Ann Med; 2018 Sep; 50(6):453-460. PubMed ID: 30103624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.